Abbott Laboratories plans Nutrition spin-off and names Daniel Salvadori CEO
FROM THE WIRE · FINANCE.YAHOO.COM
Abbott Laboratories (NYSE:ABT) plans to separate its Nutrition segment into an independent publicly traded company, targeting completion after regulatory and internal approvals. The Nutrition division, which records about US$8.5b in annual sales, will move out of Abbott into the…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralSpinning off a unit with about $8.5b in annual sales matters for the stock, though the expected impact is neutral.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Abbott plans to separate its Nutrition segment into an independent listed company.
- 02The Nutrition division records about $8.5b in annual sales.
- 03Daniel Salvadori has been appointed CEO of the future standalone Nutrition company.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets